Breast cancer Doctors Abroad — Page 4

Dr. Leyla Ozer is a medical oncologist at Memorial Bahçelievler Hospital in Istanbul. She focuses on chemotherapy, immunotherapy, and targeted therapy for cancer. Her clinical expertise includes treating gastrointestinal cancers and rare tumor types. Dr. Ozer completed her medical oncology specialization at Istanbul University.

• Served as the Head of the Medical Oncology Department at Fırat University Hospital.
• Member of the Turkish Medical Oncology Association.
• Published clinical research on breast, pancreatic, and hematologic cancers.
• Works at a LEED Platinum-certified hospital, the first of its kind in Turkey.

Professor Sezer Saglam is a leading medical oncologist at Istanbul Florence Nightingale Hospital with a record of over 1,100 successful treatments.

• Specialises in HER2-positive breast cancer cases with peer-reviewed research in biological markers
• Holds the title of Professor of Medical Oncology at Istanbul University
• Maintains active membership in the American Society of Clinical Oncology (ASCO)
• Fellowship-trained in medical oncology at the prestigious Istanbul Medical Faculty
• Recognised for research excellence with an International Best Researcher Award nomination

Dr. Kezban Nur Pilanci is a medical oncology specialist at Memorial Bahçelievler Hospital in Istanbul. She focuses on clinical oncology and has practiced at multiple major Turkish medical centers. Dr. Pilanci holds certifications as both an internal medicine and medical oncology specialist. She works at a JCI-accredited facility recognized for quality and patient safety.

• Serves as a medical oncology specialist at Memorial Bahçelievler Hospital.
• Completed oncology residency at Istanbul Science University.
• Held research roles at Istanbul University Cerrahpaşa Medical Faculty.
• Formerly served as an internal medicine specialist at Kanuni Sultan Hospital.

Dr Murat Atay is a highly focused breast surgeon who trained in sentinel node techniques at the MD Anderson Cancer Center in Texas – the top-ranked cancer hospital in the US.

• Specialises in lymphatic mapping and sentinel node biopsy to identify cancer spread with minimal tissue removal
• Focuses on breast-conserving surgery and thyroid procedures at Istanbul Florence Nightingale Hospital
• Trained at Lille University Hospital in France, bringing European clinical standards to his practice
• Expert in minimally invasive methods for managing breast cysts and monitoring oncological cases

Associate Professor Yusuf Acikgoz recently completed a prestigious medical oncology fellowship at Ohio State University, bringing global clinical trial experience to Lokman Hekim University.

• Performed 900+ oncology treatments with a focus on targeted medical therapies
• Served as an investigator for global Phase III clinical trials for breast cancer drugs
• Holds international certification in immuno-oncology from the Central European Cooperative Oncology Group
• Active member of the American Society of Clinical Oncology (ASCO)

Professor Turkan Ozturk Topcu is a specialist medical oncologist at Valued Med Hub Hospitals with international training from North America's top cancer institutes.

• Completed a fellowship at the Sunnybrook Odette Cancer Center Breast Cancer Clinic in Canada
• Conducted clinical observations at the prestigious MD Anderson Cancer Center in the USA
• Specialises in medical oncology including systemic treatments like chemotherapy and targeted therapy
• Formerly a specialist at Istanbul Göztepe Education and Research Hospital
• Expertise covers the management of both early and advanced-stage breast malignancies

Dr Saban Sec is a leading Turkish medical oncologist who serves as the Specialist Representative for the Turkish Medical Oncology Association. He specialises in tailored drug therapies for complex and high-risk breast malignancies.

• Expert in managing high-risk breast cancer involving BRCA genetic mutations
• Uses metabolic tumour volume to predict how patients respond to chemotherapy before treatment begins
• Researches how diabetes and glucose levels impact the success of preoperative chemotherapy
• Trained at major Turkish institutions including Haseki and Prof Dr Cemil Tascioglu City Hospital
• Published researcher on using HER2-targeted therapies and systemic treatments for advanced cases

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Associate Professor Hasan Mutlu is a medical oncology specialist at Medical Park Antalya who focuses on targeted cancer therapies and next-generation genetic research.

• Specialises in immunotherapy, using the body's immune system to recognise and destroy cancer cells
• Expert in targeted therapy, which uses drugs to attack specific proteins that fuel tumour growth
• Trained at Akdeniz University, one of Turkey's premier institutions for internal medicine and oncology
• Provides complementary medicine options alongside clinical treatments for better patient wellbeing
• Experienced in managing chemotherapy protocols for various stages of the disease

Professor Didem Tastekin is a senior medical oncologist at Valued Med Hub Hospitals with over a decade of specialised hospital practice in breast cancer care.

• Holds a professorship at the prestigious Istanbul University Oncology Institute
• Completed formal sub-specialist training in medical oncology for complex drug treatments
• Focuses on cancer vaccines and targeted therapies for breast tumours
• Expert in managing rare and difficult-to-treat cancer subtypes
• Member of the Turkish Medical Oncology Association